Prevalence of human T-Cell lymphotropic virus (HTLV-1/2) in individuals from public health centers in Mozambique

AIDS Research and Human Retroviruses

Volumn 26, Issue 5, 2010, Pages 559-561

  Caterino De Araujo, Adele ^a,b,c   Magri, Mariana Cavalheiro ^a,b   Costa, Emanuela Avelar Silva ^a,c   Manuel, Rolanda Carmen Rafael ^d  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c University Eduardo Mondlane ^*  (Brazil)

^d EDUARDO MONDLANE UNIVERSITY   (Mozambique)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADULT; AGING; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; ENDEMIC DISEASE; ENZYME IMMUNOASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN T LYMPHOTROPIC VIRUS 2; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MOZAMBIQUE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK FACTOR; VIRUS TRANSMISSION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; ANTIBODIES, VIRAL; FEMALE; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MALE; MIDDLE AGED; MOZAMBIQUE; PREVALENCE; PUBLIC HEALTH; RISK FACTORS; YOUNG ADULT;

EID: 77952573805     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0269     Document Type: Article

References (9)

1. Taylor GP, Bodéus M, Courtois F, et al.: The seroepidemiology of human T-lymphotropic viruses types I and II in Europe: a prospective study of pregnant women. J Acquir Immune Defic Syndr 2005;38:104-109.
2. Van Rensburg EJ, Lemmer HR, and Joubert JJ: Prevalence of viral infections in Mozambican refugees in Swaziland. East Afr Med J 1995;72:588-590.
3. Engelbrecht S, Koulinska I, Smith T-L, et al.: Subtyping of human T cell lymphotropic virus type I from tropical spastic paraparesis=HTLV-associated myelopathy patients in Mozambique. AIDS Res Hum Retroviruses 1999;15:71-72.
4. Melo J, Beby-Dcfaux A, Faria C, et al.: HIV and HTLV prevalences among women seen for sexually transmitted diseases or pregnancy follow-up in Maputo, Mozambique. J Acquir Immune Defic Syndr 2000;23:203-204.
5. Cunha L, Plouzeau C, Ingrand P, et al.: Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. J Med Virol 2007;79:1832-1840.
6. Gudo ES, Abreu CM, Mussá T, et al.: Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo city, Mozambique. Transfusion 2009;49: 1146-1150.
7. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares B, et al.: Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005;24:6058-6068.
8. Murphy EL, Watanabe K, Nass CC, et al., for the Retrovirus Epidemiology Donors Study: Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States. J Infect Dis 1999; 180:1777-1783.
9. Caterino-de-Araujo A, Manuel RCR, Del Bianco R, et al.: Seroprevalence of human herpesvirus 8 (HHV-8) infection in individuals from health care centers in Mozambique: potential for endemic and epidemic Kaposi's sarcoma. J Med Virol (in press).